BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2112456)

  • 1. The long loop reflex in spinocerebellar degeneration and motor neuron disease--its changes with TRH therapy.
    Touge T; Takeuchi H; Yamada A; Miki H; Nishioka M
    Electromyogr Clin Neurophysiol; 1990; 30(3):131-40. PubMed ID: 2112456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
    Waragai M; Ogawara K; Takaya Y; Hayashi M
    Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological and pharmacological studies of somatosensory reflex myoclonus.
    Takeuchi H; Touge T; Miki H; Yamada A; Deguchi K; Nishioka M
    Electromyogr Clin Neurophysiol; 1992 Mar; 32(3):143-54. PubMed ID: 1555529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on the clinical assessment of patients with motor neuron disease. Experience with a TRH analogue.
    Guiloff RJ; Eckland DJ
    Neurol Clin; 1987 Feb; 5(1):171-92. PubMed ID: 3104752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
    Filla A; De Michele G; Di Martino L; Mengano A; Iorio L; Maggio MA; Campanella G
    Riv Neurol; 1989; 59(2):83-8. PubMed ID: 2505370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease.
    Izumi Y; Fukuuchi Y; Ishihara N; Imai A; Komatsumoto S
    Tokai J Exp Clin Med; 1995 Dec; 20(4-6):203-8. PubMed ID: 8956461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrically elicited short and long-latency responses of intrinsic hand muscles in hereditary ataxias. Effects of isometric and ballistic isotonic voluntary contractions.
    Alfonsi E; Bono G; Mertel J; Sandrini G; Bollani E; Moglia A
    Electromyogr Clin Neurophysiol; 1992 Sep; 32(9):435-42. PubMed ID: 1396295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T; Arakawa R
    J Neurol Sci; 2009 Jun; 281(1-2):93-8. PubMed ID: 19286195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration.
    Shimizu T; Tsutsumi R; Shimizu K; Tominaga N; Nagai M; Ugawa Y; Nishiyama K; Hanajima R
    J Neurol Sci; 2020 Aug; 415():116927. PubMed ID: 32474221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of oculomotor disorders in motor neuron disease].
    Saito S; Yamamoto H
    Rinsho Shinkeigaku; 1989 Aug; 29(8):969-75. PubMed ID: 2513155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between somatosensory evoked potentials and long loop reflexes--basic investigation and its application for multiple sclerosis].
    Kaneshige Y; Matsumoto H; Chiba S; Hashimoto S; Noro H; Yanada Y
    No To Shinkei; 1989 Oct; 41(10):997-1003. PubMed ID: 2605047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-latency reflexes in patients with Behçet's disease.
    Tataroglu C; Tursen U; Unal O; Kaya TI
    J Neurol Sci; 2004 May; 220(1-2):67-71. PubMed ID: 15140608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of motor neuron diseases using intrathecal TRH. Pilot study I].
    Patrignani Ochoa J; Morales Martínez D; Martínez Parra C
    Neurologia; 1988; 3(6):221-5. PubMed ID: 3152558
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of TRH-T for the symptomatic treatment of the pathology of the upper motoneurons and electrophysiologic evaluation of its efficacy].
    Martinelli P
    Ann Ital Med Int; 1990; 5(3 Pt 2):262-9. PubMed ID: 2127688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machado-Joseph disease presenting as motor neuron disease.
    Pinto S; De Carvalho M
    Amyotroph Lateral Scler; 2008 Jun; 9(3):188-91. PubMed ID: 17963092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin-releasing hormone enhances motor neuron-evoked contractions of cultured human muscle.
    Askanas V; Engel WK; Kobayashi T
    Ann Neurol; 1985 Dec; 18(6):716-9. PubMed ID: 3936404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Some problems on the clinical phenotype of Machado-Joseph disease in relation between their ages at onset].
    Iwabuchi K; Kogure T; Oda T; Kato Y; Ohtani K; Endo K; Kosaka K; Amano N; Yagishita S
    No To Shinkei; 1993 Mar; 45(3):246-54. PubMed ID: 8323819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of follow-up survey in spinocerebellar degeneration].
    Yanagimoto S; Takayanagi T; Iizuka R; Sobue I
    Rinsho Shinkeigaku; 1989 Feb; 29(2):138-46. PubMed ID: 2752638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.
    Vucic S; Kiernan MC
    Brain; 2006 Sep; 129(Pt 9):2436-46. PubMed ID: 16835248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations and thyrotropin releasing hormone therapy in cerebellar degenerations.
    Wang HC; Chiu HC
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Mar; 47(3):161-8. PubMed ID: 1848143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.